|
EDITORIAL
BIOMARKERS: FROM STANDARDIZATION TO PERFORMANCE……………………………………………………………..183
REVIEW ARTICLE
Nada Majkić-Singh
WHAT IS A BIOMARKER? FROM ITS DISCOVERY TO CLINICAL APPLICATION………………………………………186
Patrick M.M. Bossuyt
DEFINING BIOMARKER PERFORMANCE AND CLINICAL VALIDITY…………………………………………………………193
Philippe Gillery
NONENZYMATIC POST-TRANSLATIONAL MODIFICATION DERIVED PRODUCTS:
NEW BIOMARKERS OF PROTEIN AGING………………………………………………………………………………………………….201
Diler Aslan
BIOMARKERS FOR DIABETES COMPLICATIONS: THE RESULTS OF SEVERAL CLINICAL STUDIES…….207
Miroslava Janković
GLYCANS AS BIOMARKERS: STATUS AND PERSPECTIVES…………………………………………………………………….213
Adriana Unić, Dunja Rogić, Gordana Rajsman
COPEPTIN – IS THERE A ROLE FOR ANOTHER CARDIAC BIOMARKER?………………………………………………224
Sanja Stanković, Nada Majkić-Singh
MYELOPEROXIDASE: NEW ROLES FOR AN OLD MOLECULE…………………………………………………………………230
ORIGINAL PAPER
Grazyna Sypniewska, Katarzyna Bergmann, Magdalena Krintus, Marek Kozinski, Jacek Kubica
HOW DO APOLIPOPROTEINS ApoB AND ApoA-I PERFORM
IN PATIENTS WITH ACUTE CORONARY SYNDROMES……………………………………………………………………………..237
Janko Pejović, Svetlana Ignjatović, Marijana Dajak,
Nada Majkić-Singh, Žarko Vučinić
N-TERMINAL PRO-B-TYPE NATRIURETIC PEPTIDE IN PATIENTS
WITH HYPERTENSIVE HEART DISEASE…………………………………………………………………………………………………….244
Tatjana Stanković, Vidosava Đorđević, Borislav Kamenov,
Hristina Stamenković, Vladan ]osić, Radovan Milićević, Vjeroslava Slavić
ANTIOXIDATIVE ENZYME ACTIVITIES AND LIPID PEROXIDATION IN CHILDREN WITH
INFLAMMATORY ENDOTHELIAL INJURY……………………………………………………………………………………………………..250
TECHNICAL REPORTS
IZVEŠTAJ SA XLVI SEDNICE IZVRŠNOG ODBORA DMBS
PROGRAM NAUČNIH, STRUČNIH SKUPOVA I EDUKATIVNIH SEMINARA U 2011. GODINI………………………256
Volume: 30 Belgrade, July – September 2011 Issue: 3
JMB 2011; 30 (3): 183–272 © 2011 by SMBS, Belgrade
|
